Brief: Bionaturis takes part in development of vaccine against cervical cancer

Biotechnology Assets SA

12/01/2016 10:44

Jan 12 (Reuters) - Bioorganic Research and Services SA 
 BNT.MC : 
    * Says that Bionaturis Group takes part in the development 
of a cost-effective and possibly oral vaccine against cervical 
cancer 
    * Development of vaccine against cervical cancer project is 
led by German BioEnergy GmbH & Consultant with participation 
from the German Cancer Research Center 
 
     
Source text: http://bit.ly/1RjGdYN 
     
Further company coverage:  BNT.MC  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))